Back to search
Long Term Cancer Side Effects
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Long Term Cancer Side Effects trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Long Term Cancer Side Effects trials you may qualify forThis is a global extension study to provide continued access to niraparib and further characterize the long-term safety of niraparib treatment in participants w…
Aromatase inhibitors are the most used endocrine therapy for hormone-positive breast cancer. Despite the evidence that aromatase inhibitor therapy is associated…
Intensified chemotherapy is an effective treatment in 30-70% of patients with refractory germ cell tumor. Since most cases are diagnosed before the age of 40, s…
Rationale: In addition to surgery, effective breast cancer (BC) treatment typically requires chemotherapy, radiotherapy, or both. However, it is still unclear w…
This study evaluates whether there are pre-treatment factors such as patient characteristics, specific breast cancer type, specific treatments, toxicities, or a…
While the sequelae and toxicities after ovarian and endometrial cancer treatments are well described in the literature, the actual needs of patients for support…